124
Participants
Start Date
December 5, 2023
Primary Completion Date
December 30, 2024
Study Completion Date
July 15, 2025
Teriflunomide
Starting dose of 7 mg once daily. Dose adjustments are made throughout the study based on individual platelet counts.
Danazol
200 mg twice daily.
RECRUITING
Peking University Insititute of Hematology, Peking University People's Hospital, Beijing
Beijing Luhe Hospital
OTHER
Chinese PLA General Hospital
OTHER
Navy General Hospital, Beijing
OTHER
Beijing Hospital
OTHER_GOV
Beijing Friendship Hospital
OTHER
Peking University First Hospital
OTHER
Peking University Third Hospital
OTHER
China-Japan Friendship Hospital
OTHER
Beijing Tsinghua Changgeng Hospital
OTHER
Peking University People's Hospital
OTHER